De Novo
DEN040004: CELLERATION MIST THERAPY SYSTEM
FDA De Novo · celleration · decided Jun 25, 2004
Key facts
| De Novo number | DEN040004 |
|---|---|
| Device name | CELLERATION MIST THERAPY SYSTEM |
| Applicant | celleration |
| Product code | NRB |
| Date received | Apr 29, 2004 |
| Decision date | Jun 25, 2004 |
| Decision | granted (DENG) |
| FDA classification | Class II |
| Review panel | General & Plastic Surgery |
At a glance
- None Later 510(k)s citing this De Novo
- None UDI device identifiers (GUDID)
- None MAUDE adverse event reports
- None Recall events
- No Decision summary on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About De Novo classification requests
The De Novo pathway classifies novel low- to moderate-risk devices that have no legally marketed predicate; each granted request creates a new classification regulation and product code.
Source: U.S. Food and Drug Administration (FDA), De Novo database · Source date: